These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33559731)

  • 1. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
    Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
    Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
    Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
    Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
    Gen Thorac Cardiovasc Surg; 2019 Nov; 67(11):949-954. PubMed ID: 30972530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
    Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
    Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Sarcopenia on Surgical Outcomes in Non-small Cell Lung Cancer.
    Shinohara S; Otsuki R; Kobayashi K; Sugaya M; Matsuo M; Nakagawa M
    Ann Surg Oncol; 2020 Jul; 27(7):2427-2435. PubMed ID: 31970570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Computed Tomography-Determined Sarcopenia and Postoperative Outcome After Surgery for Non-Small Cell Lung Cancer.
    Kim EY; Lee HY; Kim KW; Lee JI; Kim YS; Choi WJ; Kim JH
    Scand J Surg; 2018 Sep; 107(3):244-251. PubMed ID: 29284364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
    Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
    J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification based on skeletal muscle mass and the severity of lung emphysema impacts on clinical outcomes after anatomical resection for lung cancer.
    Tsubokawa N; Mimura T; Tadokoro K; Yamashita Y
    Jpn J Clin Oncol; 2022 Aug; 52(8):917-924. PubMed ID: 35438159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
    Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
    Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and cancer recurrence associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small cell lung cancer.
    Nakada T; Noda Y; Kato D; Shibasaki T; Mori S; Asano H; Matsudaira H; Hirano J; Odaka M; Ohtsuka T
    Thorac Cancer; 2019 Oct; 10(10):1945-1952. PubMed ID: 31436042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
    Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.
    Tsukioka T; Nishiyama N; Izumi N; Mizuguchi S; Komatsu H; Okada S; Toda M; Hara K; Ito R; Shibata T
    Jpn J Clin Oncol; 2017 Apr; 47(4):363-368. PubMed ID: 28158497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Akazawa A
    PLoS One; 2021; 16(9):e0257594. PubMed ID: 34551011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer.
    Sato S; Sato M; Shinohara H
    Gen Thorac Cardiovasc Surg; 2023 Jun; 71(6):354-362. PubMed ID: 36562876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer.
    Ushitani Y; Shimada Y; Yamada Y; Kudo Y; Yamada T; Tanaka T; Ohira T; Ikeda N
    Ann Surg Oncol; 2022 Oct; 29(11):6922-6931. PubMed ID: 35729292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer.
    Huang DD; Wang SL; Zhuang CL; Zheng BS; Lu JX; Chen FF; Zhou CJ; Shen X; Yu Z
    Colorectal Dis; 2015 Nov; 17(11):O256-64. PubMed ID: 26194849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.